|The Many Facets of Dacryoadenitis|
... other inflammatory lacrimal gland lesions, even lymphoproliferative ones. To identify IgG4-related dacryoadenitis, particularly when there is no documented disease elsewhere, the criteria have been strengthened toward abundant IgG4-positive plasma ...
Medscape - Thu, 08 Oct 2015 21:18
|Treatment Effects Maintained Over Five Years in Majority of Patients with ...|
LEMTRADA may cause an increased risk of malignancies, including thyroid cancer, melanoma, and lymphoproliferative disorders. Perform baseline and yearly skin exams. Because of the risk of autoimmunity, infusion reactions, and malignancies, ...
MarketWatch - Wed, 07 Oct 2015 22:01
|Dr. Roach: Strange 'pimples' may be rare disease|
Dear R.R.: Lymphomatoid papulosis is a rare disease. It is in the category of cutaneous lymphoproliferative disorders. It is a chronic disease, and lasts years or even decades. The underlying cause is not known exactly, but it is related in many ways ...
The Detroit News - Mon, 21 Sep 2015 14:33
|New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People ...|
The risk of malignancy, particularly lymphoproliferative disorders, or infection may be increased with the use of some medications with immunosuppressive potential, including teriflunomide. Peripheral neuropathy, including polyneuropathy and ...
MarketWatch - Wed, 07 Oct 2015 00:01
|To Your Good Health: Strange pimples may be rare disease|
It is in the category of cutaneous lymphoproliferative disorders. It is a chronic disease, and lasts years or even decades. The underlying cause is not known exactly, but it is related in many ways to other lymphoproliferative diseases, such as mycosis ...
SouthCoastToday.com - Mon, 21 Sep 2015 17:22
|Recent advances in RASopathies|
These disorders include the following: (1) neurofibromatosis type 1 (NF1) caused by haploinsufficiency of neurofibromin; (2) NF1-like syndrome caused by haploinsufficiency of SPRED1; (3) Noonan syndrome (NS) caused by mutations in PTPN11, SOS1, RAF1 ...
Nature.com - Wed, 07 Oct 2015 23:11
|Breakthrough T-Cell Therapy Halts EBV-Associated Lymphoproliferative Disorders|
Infusions of Epstein-Barr virus (EBV)–specific cytotoxic T lymphocytes (CTLs) from healthy donors led to high response rates and significant extensions in overall survival (OS) for patients with rituximab-refractory EBV–associated lymphoproliferative ...
OncLive - Sun, 19 Apr 2015 06:10
|Managing severe pediatric atopic dermatitis|
For rituximab, which has approved indications for lymphomas and autoimmune diseases, there are data about its use in children with post-transplant lymphoproliferative disorders. Dr. Siegfried says she has used rituximab for one child with severe AD.
ModernMedicine - Fri, 11 Sep 2015 08:48